RIBOLIFE-B (06938.HK): Included in Hang Seng Composite Index constituents and Stock Connect list effective 7 September

NewTimeSpace News: On 7 September 2026, Suzhou Ribo Life Science Co., Ltd. (stock code: 06938) voluntarily announced that, according to announcements published by Hang Seng Indexes Company Limited, the Company's shares have been included as constituents of the Hang Seng Composite Index and included in the eligible securities lists under the southbound trading of the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect ("Stock Connect"), effective from 7 September 2026.

The inclusion of the Company's shares as constituents of the Hang Seng Composite Index and eligible securities under Stock Connect is regarded by the Company as an important milestone in its development in the capital markets and an important step in deeply integrating into the Mainland Chinese and international capital markets and serving the national strategy for high-quality development of the biomedical industry, reflecting the capital markets' high recognition of the Company's performance, core values, corporate governance standards and development potential. Following the implementation of Stock Connect, the Company expects to significantly improve the liquidity of its shares, broaden its investor base, further optimise its shareholder structure, and enhance market attention and influence in the capital markets.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.